Cargando…
Who and what influences delayed presentation in breast cancer?
This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome measures were patient delay in prese...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150175/ https://www.ncbi.nlm.nih.gov/pubmed/9579844 |
_version_ | 1782144590121271296 |
---|---|
author | Burgess, C. C. Ramirez, A. J. Richards, M. A. Love, S. B. |
author_facet | Burgess, C. C. Ramirez, A. J. Richards, M. A. Love, S. B. |
author_sort | Burgess, C. C. |
collection | PubMed |
description | This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome measures were patient delay in presentation to the general practitioner and non-referral by the general practitioner to hospital after the patient's first visit. Nineteen per cent of patients delayed > or = 12 weeks. Patient delay was related to clinical tumour size > or = 4 cm (P = 0.0002) and with a higher incidence of locally advanced and metastatic disease (P = 0.01). A number of factors predicted patient delay: initial breast symptom(s) that did not include a lump (OR 4.5, P = 0.003), not disclosing discovery of the breast symptom immediately to someone else (OR 6.0, P < 0.001), seeking help only after being prompted by others (OR 4.4, P = 0.007) and presenting to the general practitioner with a non-breast problem (OR 3.5, P = 0.03). Eighty-three per cent of patients were referred to hospital directly after their first general practitioner visit. Presenting to the GP with a breast symptom that did not include a lump independently predicted general practitioner delay (OR 3.6, P = 0.002). In view of the increasing evidence that delay adversely affects survival, a large multicentre study is now warranted to confirm these findings that may have implications for public and medical education. |
format | Text |
id | pubmed-2150175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-21501752009-09-10 Who and what influences delayed presentation in breast cancer? Burgess, C. C. Ramirez, A. J. Richards, M. A. Love, S. B. Br J Cancer Research Article This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome measures were patient delay in presentation to the general practitioner and non-referral by the general practitioner to hospital after the patient's first visit. Nineteen per cent of patients delayed > or = 12 weeks. Patient delay was related to clinical tumour size > or = 4 cm (P = 0.0002) and with a higher incidence of locally advanced and metastatic disease (P = 0.01). A number of factors predicted patient delay: initial breast symptom(s) that did not include a lump (OR 4.5, P = 0.003), not disclosing discovery of the breast symptom immediately to someone else (OR 6.0, P < 0.001), seeking help only after being prompted by others (OR 4.4, P = 0.007) and presenting to the general practitioner with a non-breast problem (OR 3.5, P = 0.03). Eighty-three per cent of patients were referred to hospital directly after their first general practitioner visit. Presenting to the GP with a breast symptom that did not include a lump independently predicted general practitioner delay (OR 3.6, P = 0.002). In view of the increasing evidence that delay adversely affects survival, a large multicentre study is now warranted to confirm these findings that may have implications for public and medical education. Nature Publishing Group 1998-04 /pmc/articles/PMC2150175/ /pubmed/9579844 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Burgess, C. C. Ramirez, A. J. Richards, M. A. Love, S. B. Who and what influences delayed presentation in breast cancer? |
title | Who and what influences delayed presentation in breast cancer? |
title_full | Who and what influences delayed presentation in breast cancer? |
title_fullStr | Who and what influences delayed presentation in breast cancer? |
title_full_unstemmed | Who and what influences delayed presentation in breast cancer? |
title_short | Who and what influences delayed presentation in breast cancer? |
title_sort | who and what influences delayed presentation in breast cancer? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150175/ https://www.ncbi.nlm.nih.gov/pubmed/9579844 |
work_keys_str_mv | AT burgesscc whoandwhatinfluencesdelayedpresentationinbreastcancer AT ramirezaj whoandwhatinfluencesdelayedpresentationinbreastcancer AT richardsma whoandwhatinfluencesdelayedpresentationinbreastcancer AT lovesb whoandwhatinfluencesdelayedpresentationinbreastcancer |